menu search

Morgan stanley says anti-obesity drugs have trimmed market value by $258bn

An interesting snippet from analysts at Morgan Stanely on a not-so-fat result:GLP-1 medications like Ozempic have seen a $340 billion uplift in market...

October 19, 2023, 10:20 pm

Terns pharmaceuticals to participate in upcoming investor conferences

FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...

October 19, 2023, 8:05 pm

Ge healthcare teams up with novo nordisk to treat diabetes without drugs

GE HealthCare Technologies Inc. GEHC, -2.35% on Thursday said it is teaming up with Novo Nordisk NVO, -0.58% to develop an ultrasound treatment for ty...

October 19, 2023, 8:36 am

Viking therapeutics joins weight loss drug bandwagon as trial data impresses

Viking Therapeutics (NASDAQ:VKTX) shares shot up 12% in overnight US trading as the drug developer revealed more impressive trial data from a treatmen...

October 18, 2023, 7:06 am

Pepsico: strong growth driven by pricing and glp-1 anti-obesity drug is non-structural

PepsiCo has experienced strong net pricing growth over the past decade, driven by portfolio premiumization and innovative product offerings. Concerns ...

October 18, 2023, 1:19 am

Global market for anti-obesity drugs could reach $100b by 2030: goldman sachs

A report from Goldman Sachs predicts that the total addressable market globally for weight loss drugs could reach $100 billion dollars in sales by 203...

October 17, 2023, 5:35 pm

Earnings results: johnson & johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech business

Company raises full-year profit and sales guidance and pursues multipronged strategy to address talc-powder litigation. Read Full Story The post Earni...

October 17, 2023, 3:08 pm

Snack maker mondelez int'l is down but not out

In an unprecedented battle between modern medicine and traditional snacks, Mondelez International, Inc. NASDAQ: MDLZ appears to be losing. Since a  W...

October 16, 2023, 12:21 pm

Carmot therapeutics highlights clinical data from its pipeline of treatments for obesity and diabetes at obesityweek®

– CT-388 administered once-weekly resulted in clinically meaningful weight loss and insulin sensitivity over a 4 week treatment period in participan...

October 15, 2023, 4:00 pm

U.s. physical therapy: positioned for market dominance amidst attractive valuations

USPH has a substantial presence in the physical therapy industry, with 662 clinics in 41 states, particularly Texas and Tennessee. Acquisitions, prima...

October 13, 2023, 6:16 pm

Scholar rock (srrk) up on pipeline advancement, stock offering

Scholar Rock (SRRK) rises on plans to advance SRK-439 for treating obesity and offering common stock....

October 13, 2023, 2:16 pm

Why scholar rock holding stock soared today

Scholar Rock announced it will advance the development of its obesity treatment, SRK-439, starting with...

October 12, 2023, 4:17 pm

Jim cramer is weighing out the risks of weight loss drugs

'Mad Money' host Jim Cramer takes a deep dive into the impact of obesity drugs on various sectors....

October 11, 2023, 7:36 pm

Eli lilly: the glp-1 opportunity, while increasingly recognized, is vastly underestimated

Eli Lilly is expected to receive FDA approval for tirzepatide, an obesity medication, and has two other...

October 11, 2023, 5:33 pm

Thyroid function test market thrives with a 4.2% cagr, predicted us$ 2.64 billion by 2033 | future market insights, inc.

The United States is projected to dominate the thyroid function test market, with a 3.5% CAGR from 2023 to 2033. Government-funded endocrinology resea...

October 11, 2023, 12:30 pm

Sugar substitute market predicted to reach us$ 28.57 billion by 2033: growth and trends | future market insights, inc.

Sugar substitutes gradually finding their place in the food and beverages industry. The market foresees exponential growth in the coming decade. Risin...

October 10, 2023, 4:30 pm

Eli lilly pipeline of obesity treatments is positioned to pay off beyond just mounjaro, analysts say

Shares of Eli Lilly and Co (NYSE:LLY) rose Friday after analysts at Bank of America reaffirmed its confidence in the company. The firm reiterated its ...

October 6, 2023, 3:01 pm

Coca-cola, pepsi: will weight loss drugs hit food and drink sector proifits?

An end may be in sight to America's national obesity epidemic. However, a slimline population probably...

October 6, 2023, 9:31 am

Wegovy class has higher gi side effect risk than older weight loss drug in study

Medicines in the same class as Novo Nordisk's popular weight-loss therapy Wegovy may carry an increased risk of pancreatitis, intestinal blockage, and...

October 5, 2023, 2:31 pm

Eli lilly exec behind diabetes blockbuster set retire

Mike Mason, the executive vice president and president of Lilly Diabetes & obesity at Eli Lilly and Co ...

October 4, 2023, 8:34 am


Search within

Pages Search Results: